Daysee Kit
Product Images NDC 68180-846

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Daysee (NDC 68180-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (2396d26d C419 4eca B5ba B78becc16fde 01)

A horizontal bar chart titled 'Likelihood of Developing a VTE' comparing the number of women out of 10,000 with a blood clot among different groups: Non-Pregnant Non-COC users (range 1 to 5), COC users (range 3 to 9), Pregnant women (range 5 to 20), and Postpartum women (12 weeks only) with the highest range (40 to 65). The x-axis represents the number of women with a blood clot from 0 to 70.*

FDA Label Image

Figure 2 (2396d26d C419 4eca B5ba B78becc16fde 02)

A bar chart depicting percentages of bleeding and/or spotting and bleeding alone for Daysee (Levonorgestrel and Ethinyl Estradiol) over four cycles of use. The x-axis shows cycles 2 to 4 with day ranges and sample sizes, while the y-axis shows percentage from 0% to 80%. Each cycle has paired bars representing bleeding and bleeding plus spotting for periods of ≥7 days and ≥20 days.*

FDA Label Image

Figure 3 (2396d26d C419 4eca B5ba B78becc16fde 03)

A forest plot showing study effect estimates comparing combination oral contraceptive (COC) use versus never use, including odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals from multiple cohort studies between 2005 and 2022. Studies are grouped into 'Ever COC vs. Never COC Use' and 'Current COC Use vs. Never-Use,' with effect estimates plotted against zero and one on the x-axis labeled 'Effect Estimate.'*

FDA Label Image

Levonorgestrel (2396d26d C419 4eca B5ba B78becc16fde 04)

Chemical structure of levonorgestrel, showing its molecular formula C21H28O2 and molecular weight 312.4. The diagram depicts the specific arrangement of atoms and bonds in the levonorgestrel molecule.*

FDA Label Image

Ethinyl Estradiol (2396d26d C419 4eca B5ba B78becc16fde 05)

Chemical structure diagram of Ethinyl Estradiol, showing the molecular formula C20H24O2 and a molecular weight of 296.4.*

FDA Label Image

Trade Mark (2396d26d C419 4eca B5ba B78becc16fde 06)

FDA Label Image

Image (2396d26d C419 4eca B5ba B78becc16fde 07)

An infographic categorizing birth control methods by effectiveness measured in pregnancies per 100 women per year. Categories range from fewer than 1 pregnancy with implants, injections, intrauterine devices, and sterilization, to 10-20 pregnancies with condoms and diaphragms, to the highest rates with no birth control or withdrawal methods.*

FDA Label Image

Blister (2396d26d C419 4eca B5ba B78becc16fde 08)

An instructional diagram with a weekly layout indicating days of the week from Sunday to Saturday across four rows labeled Week 1 through Week 4. The diagram shows a sequential arrow path starting from 'START HERE' on Sunday of Week 1, guiding through each day in order. Each day is represented by empty circles to be filled or marked, illustrating a visual schedule or planner format, likely for daily tracking or dosage.*

FDA Label Image

Blister (2396d26d C419 4eca B5ba B78becc16fde 09)

Diagram illustrating the weekly dosage schedule for the Daysee kit containing levonorgestrel and ethinyl estradiol. It shows circular placeholders arranged in rows for each day of the week, labeled Sunday through Saturday, across Weeks 5 to 13. Arrows indicate the progression for taking each daily dose within the 13-week cycle.*

FDA Label Image

Trade Mark (2396d26d C419 4eca B5ba B78becc16fde 10)

FDA Label Image

Pouch Label: 1 Extended-cycle Blister Card Of 91 Tablets (2396d26d C419 4eca B5ba B78becc16fde 11)

Daysee kit containing levonorgestrel and ethinyl estradiol tablets USP (0.15 mg/0.03 mg) and ethinyl estradiol tablets USP (0.01 mg) by Lupin Pharmaceuticals, Inc. The label states it is a prescription-only product with an extended-cycle blister pack of 91 tablets. The design includes dosage information and storage instructions on a pink gradient background.*

FDA Label Image

Carton Label: 2 Extended-cycle Blister Card Of 91 Tablets Each (2396d26d C419 4eca B5ba B78becc16fde 12)

Packaging label for Daysee, a prescription kit containing levonorgestrel (0.15 mg) and ethinyl estradiol (0.03 mg) tablets plus ethinyl estradiol tablets (0.01 mg). The label states 2 extended-cycle blisters of 91 tablets each, distributed by Lupin Pharmaceuticals, Inc. The label includes dosage details, product NDC 68180-846-73, barcodes, and manufacturing information from Lupin Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.